SCHEMBL24604285

SCHEMBL24604285

CCOc1ccc(Cc2cnc(Cl)s2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.63
TDP1 Q9NUW8 1/20 0.63
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
POLB P06746 2/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
LMNA P02545 2/20 0.50
RAB9A P51151 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ATM Q13315 1/20 0.50
HPGD P15428 1/20 0.50
MAPT P10636 4/20 0.48
ALDH1A1 P00352 2/20 0.48
GAA P10253 1/20 0.48
DHFR P00374 1/20 0.46
NQO1 P15559 1/20 0.45
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20929533 0.76 EPHX2 (0.67) L3MBTL1TDP1KMT2AMEN1CYP1A2
SCHEMBL17410524 0.75 LMNA (0.61) L3MBTL1TDP1KMT2AMEN1CYP1A2
SCHEMBL20929556 0.75 L3MBTL1 (0.45) L3MBTL1TDP1KMT2AMEN1CYP1A2
SCHEMBL2872167 0.75 NQO1 (0.47) L3MBTL1TDP1KMT2APOLBSMN1; SMN2
SCHEMBL2488793 0.74 NQO1 (0.74) TDP1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL23352201 0.73 KMT2A (0.47) L3MBTL1TDP1KMT2AMEN1CYP2C9
SCHEMBL2868852 0.72 NQO1 (0.47) L3MBTL1TDP1KMT2AMEN1POLB
SCHEMBL23352198 0.71 ADRB2 (0.47) L3MBTL1TDP1KMT2AMEN1CYP1A2
SCHEMBL24604286 0.71 L3MBTL1 (0.48) L3MBTL1TDP1KMT2AMEN1CYP1A2
SCHEMBL12585035 0.70 MEN1 (0.76) L3MBTL1TDP1KMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022147210-A1 ANTI-TUMOR COMPOSITIONS AND METHODS EVRYS BIO, LLC (US) 2022-07-07 WO disclosed